Archive for November 2009
Erdem E, Zeng H, Zhou J, Shi J, Wells DL. Investigation of RFID tag readability for pharmaceutical products at item level. Drug Dev Ind Pharm. 2009;35(11):1312-24.
BACKGROUND: The applications of radio frequency identification (RFID) technology carry a tremendous potential for pharmaceutical industry. There is a pressing need to analyze the performance of RFID tags attached to various pharmaceutical dosage forms. METHOD: The readability of RFID-tagged pharmaceutical products is, for the first time, systematically investigated by experiments. Factors considered include dosage forms,…
[...]Partnerka, Counterfeit Drugs and the New Counterfeit Spam
The Partnership for Safe Medicines (PSM) has long reported on the growing issue of pharmaceutical spam advertising—and now SophosLab Canada has taken a closer look at the solicitation of counterfeit products online.
[...]Spotlight on KnujOn: Combating Counterfeits Online – Conclusion
This is concludes our interview with Garth Bruen, co-founder of KnujOn, an internet compliance company, on the subjects of counterfeit drugs sold online, search engine advertising what’s needed from regulators to protect Web users. PSM: FDA is preparing to receive public remarks regarding the online promotion of medical products and adverse event reporting. What recommendations…
[...]Consumer Protection Group Applauds International Efforts to Combat Illegal Online Pharmacies
The Partnership for Safe Medicines (PSM) issued the following statement regarding the International Internet Week of Action, code named Operation Pangea II, intended to curb illegal actions involving medical products. PSM is a group of organizations and individuals dedicated to protecting consumers from counterfeit medicines.
[...]Spotlight on KnujOn: Combating Counterfeits Online, Part 4
This is part four of our interview with Garth Bruen, co-founder of KnujOn, an internet compliance company. We talked to him about the KnujOn system, search engine advertising and what’s needed from regulatory bodies to protect Web users from counterfeit and substandard drug solicitations online. Read: Part 1 | Part 2 | Part 3 PSM:…
[...]Spotlight on KnujOn: Combating Counterfeits Online, Part 3
This is part three of our interview with Garth Bruen, co-founder of KnujOn, an internet compliance company. We talked to him about the KnujOn system, search engine advertising and what’s needed from regulatory bodies to protect Web users from counterfeit and substandard drug solicitations online. Read: Part 1 | Part 2 PSM: What steps have…
[...]Lewis K. China’s counterfeit medicine trade booming. CMAJ. 2009;181(10):E237-8.
It was a cringe-worthy moment for China when 600 000 counterfeit antimalarial tablets were intercepted by the Nigerian government in June. Produced and shipped from China, they bore an unexpected label: "Made in India." Even the fakes were being faked. It was a new low. Many things are faked in China —from Gucci sunglasses to…
[...]Spotlight on KnujOn: Combating Counterfeits Online, Part 2
This is part two of an interview with Garth Bruen, the co-founder of KnujOn, an internet compliance company, on the KnujOn system, search engine advertising and what’s needed from regulatory agencies to protect consumers from counterfeit medical products advertised online. Read part one of our interview. PSM: Have you noticed an uptick in the number…
[...]Spotlight on KnujOn: Combating Counterfeits Online, Part 1
The dangers of online pharmacies and unlicensed drug sellers are well documented. In fact, recent reports released by KnujOn, an internet compliance company, found that 80 to 90 percent of search engine-sponsored advertisements of online drug pharmacies violate federal and state laws, including selling substandard and counterfeit drugs to unsuspecting consumers. To make matters worse,…
[...]“Safe” Country Focus: United Kingdom
As my colleague Thomas Kubic recently noted, most supporters of drug importation have a faulty assumption that developed countries like Canada, Australia, Japan and the 27 members of the European Union (E.U.) are insulated from the global threat of counterfeit drugs. In the coming weeks, we will take a closer look at some of these so-called “safe” countries and illustrate why there is no such thing as a “safe” country when it comes to drug importation.
[...]